Comparison of the Medication Adherence of Patients Treated With Telmisartan/Hydrochlorothiazide or Telmisartan/Amlodipine FDC Versus Double-pill Combination Therapy in Real-world Japanese Therapeutic Practice
Active, no longer recruiting
Phase of Trial: Phase IV
Latest Information Update: 17 Dec 2018
At a glance
- Drugs Amlodipine/telmisartan (Primary) ; Telmisartan/hydrochlorothiazide (Primary) ; Amlodipine; Telmisartan
- Indications Hypertension
- Focus Therapeutic Use
- Sponsors Boehringer Ingelheim
- 30 Jan 2018 Status changed to active, no longer recruiting as per the investigators reply (email@example.com dated: 29 Jan 2018)
- 22 Dec 2017 Planned End Date changed from 28 Dec 2017 to 12 Jan 2018.
- 22 Dec 2017 Planned primary completion date changed from 28 Dec 2017 to 12 Jan 2018.